Skip to content
Delayed ~15 min

CMPX COMPASS THERAPEUTICS

Health Care · Russell 2000

Next earnings: Tue 10 Nov 2026 · estimated

What 19 analyst firms say about COMPASS THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

0.76 USD+0.07 (+10.84%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+1,228.9%to the avg target 10.08 USD+9.32 USD
Buy 14 · Hold 3 · Sell 0

17 rated views · 20 analyst/firm records · 19 firms

Latest report23 Sep 2026avg report date 5 Aug
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
  • Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD

Recent analyst activity · last 90 days

Our tracked history has 13 reports on CMPX from 11 analyst firms in the last 90 days (19 firms in the past year).

Comparing each firm's latest target with its previous one: 3 lowered it, 3 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Citizens lowered its target from $10.00 (set 28 Apr 2026) to $4.00 on 23 Sep 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Canaccord GenuityJohn L NewmanBuy23 Sep 20267.00 USD
Cantor FitzgeraldLi WatsekBuy23 Sep 2026—
CitigroupUnnamed analystBuy23 Sep 2026—
Citizens JMPReni J. BenjaminBuy23 Sep 20264.00 USD
Craig-HallumAlbert LoweBuy17 Aug 20268.00 USD
D Boral CapitalJason KolbertBuy27 Apr 202630.00 USD
D Boral CapitalPatrick MccannBuy21 May 202628.00 USD
GuggenheimMichael SchmidtBuy23 Sep 20264.00 USD
H.C. WainwrightJoseph PantginisBuy6 Aug 202612.00 USD
JefferiesMaury RaycroftBuy23 Sep 20263.00 USD
Ladenburg ThalmannKevin M DegeeterBuy1 Jul 2026Conflicting reports · excluded
Leerink PartnersAsthika GoonewardeneBuy21 Jul 20267.00 USD
Lifesci CapitalCharles ZhuHold22 Sep 20266.00 USD
Piper SandlerBiren AminBuy7 Aug 20266.00 USD
Raymond JamesSean MccutcheonHold6 Aug 2026—
StifelStephen Willey—1 Jun 20266.00 USD
WedbushRobert DriscollConflictConflicting reports · excluded23 Sep 2026Conflicting reports · excluded
Weiss RatingsUnnamed analyst—15 Oct 2026—
William BlairMatt PhippsBuy7 Aug 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 08:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.